AAPG · Forms 3, 4, 5
Insider trades at ASCENTAGE PHARMA GROUP INTERNATIONAL
No open-market insider buys or sells at ASCENTAGE PHARMA GROUP INTERNATIONAL in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for ASCENTAGE PHARMA GROUP INTERNATIONAL in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Faical Miyara | Chief Business Officer | Became an insider (Form 3) | Form 3 | ||||
| Yifan Zhai | Chief Medical Officer | Option exercise | 92,746 | Form 4 | |||
| Yifan Zhai | Chief Medical Officer | Option exercise | 95,575 | Form 4 | |||
| Dajun Yang | Chairman and CEO | Option exercise | 95,575 | Form 4 | |||
| Dajun Yang | Chairman and CEO | Option exercise | 92,746 | Form 4 | |||
| Veet Misra | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Veet Misra | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Jin Cao | Chief Accounting Officer | Became an insider (Form 3) | Form 3 | ||||
| Yifan Zhai | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Ren Wei | Director | Became an insider (Form 3) | Form 3 | ||||
| Shaomeng Wang | Director | Became an insider (Form 3) | Form 3 | ||||
| Thomas J Knapp | SVP/General Counsel | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.